Outcomes of Antiretroviral Treatment Programs in Rural Southern Africa
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Data on outcomes of antiretroviral treatment (ART) programs in rural sub-Saharan African are scarce. We describe early losses and long-term outcomes in 6 rural programs in Southern Africa with limited access to viral load monitoring and second-line ART. METHODS: Patients aged ≥16 years starting ART in 2 programs each in Zimbabwe, Mozambique, and Lesotho were included. We evaluated risk factors for no follow-up after starting ART and mortality and loss to follow-up (LTFU) over 3 years of ART, using logistic regression and competing risk models. Odds ratios and subdistribution hazard ratios, adjusted for gender, age category, CD4 category, and World Health Organization stage at start of ART are reported. RESULTS: Among 7725 patients, 449 (5.8%) did not return after initiation of ART. During 9575 person-years, 698 (9.6%) of those with at least 1 follow-up visit died, and 1319 (18.1%) were LTFU. At 3 years, the cumulative incidence of death and LTFU were 12.5% (11.5%-13.5%) and 25.4% (24.0%-26.9%), respectively, with important differences between countries as follows: in Zimbabwe 75.1% (72.8%-77.3%) were alive and on ART at 3 years compared with 55.4% (52.8%-58.0%) in Lesotho and 51.6% (48.0%-55.2%) in Mozambique. In all settings, young age and male gender predicted LTFU, whereas advanced clinical stage and low baseline CD4 counts predicted death. CONCLUSIONS: In African ART programs with limited access to second-line treatment, mortality, and LTFU are high in the first 3 years of ART. Low retention in care is a major threat to the sustainability of ART delivery in Southern Africa, particularly in rural sites.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adherence to Antiretroviral Therapy in Sub-Saharan Africa and North America: A Meta-analysis
Mills, E. J., Nachega, J. B., Buchan, I., Orbinski, J., Attaran, A., Singh, S., Rachlis, B., Wu, P., Cooper, C., Thabane, L., et al. (2006) · JAMA · doi:10.1001/jama.296.6.679 · Cited by 899 · cited 9×
“The World Health Organization (WHO) estimates that more than 5 million HIV-1–infected people were receiving antiretroviral therapy (ART) in low-income and middle-income countries by the end of 2009.1 However, high mortality and loss of patients to follow-up in the context of the rapid scale-up of ART and weak health s…”
BackgroundInfluentialMay, M., Boulle, A., Phiri, S., Messou, E., Myer, L., Wood, R., Keiser, O., Sterne, J. A., Dabis, F., & Egger, M. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60666-6 · Cited by 250 · cited 9×
“The World Health Organization (WHO) estimates that more than 5 million HIV-1–infected people were receiving antiretroviral therapy (ART) in low-income and middle-income countries by the end of 2009.1 However, high mortality and loss of patients to follow-up in the context of the rapid scale-up of ART and weak health s…”
ResultInfluentialSelf-citation
Cited by
Fox, M. P., & Rosen, S. (2015) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000553 · Cited by 306
Iwelunmor, J., Blackstone, S., Veira, D., Nwaozuru, U., Airhihenbuwa, C., Munodawafa, D., Kalipeni, E., Jutal, A., Shelley, D., & Ogedegbe, G. (2015) · Implementation Science · doi:10.1186/s13012-016-0392-8 · Cited by 219
“Good and well trained health care workers; consistent delivery of services [31, 37, 52] 9.”
BackgroundCommunity‐supported models of care for people on HIV treatment in sub‐Saharan Africa
Bemelmans, M., Baert, S., Goemaere, E., Wilkinson, L., Vandendyck, M., van Cutsem, G., Silva, C., Perry, S., Szumilin, E., Gerstenhaber, R., et al. (2014) · Tropical Medicine & International Health · doi:10.1111/tmi.12332 · Cited by 197
Indravudh, P. P., Sibanda, E. L., d’Elbée, M., Kumwenda, M. K., Ringwald, B., Maringwa, G., Simwinga, M., Nyirenda, L. J., Johnson, C. C., Hatzold, K., et al. (2017) · AIDS · doi:10.1097/qad.0000000000001516 · Cited by 170
“Late HIV diagnosis, delays in antiretroviral therapy (ART) initiation and poor adherence to treatment has resulted in poor clinical outcomes among this age group [4-7].”
BackgroundStern, E., Colvin, C., Gxabagxaba, N., Schutz, C., Burton, R., & Meintjes, G. (2017) · African Journal of AIDS Research · doi:10.2989/16085906.2017.1285795 · Cited by 30
Metadata
- Authors
- Wandeler, G., Keiser, O., Pfeiffer, K., Pestilli, S., Fritz, C., Labhardt, N. D., Mbofana, F., Mudyiradima, R., Emmel, J., Egger, M., & Ehmer, J.
- Venue
- JAIDS Journal of Acquired Immune Deficiency Syndromes
- Published
- 2012-02-01
- Volume
- 59
- Issue
- 2
- Pages
- e9-e16
- ISSN
- 1525-4135 (ISSN-L)
- OpenAlex
- W2041972845
- Cited by
- 77
- References
- 2
- FWCI
- 5.81
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.